Cell and Gene at the Abbey
Production, Scale-up and Global Harmonisation
Conference Agenda
DAY 01: 10TH NOVEMBER 2021 | |||
---|---|---|---|
TIME | SPEAKER | COMPANY | TITLE OF TALK |
09.00 | Aoife Duffy / Brian Harrison | HiTech Health | Introduction and Update on HTH Cell & Gene Therapy Programme |
09.15 | Prof. Francesco Curcio | University of Udine | Clinical use of MSCs: the experience at the University of Udine Medical Centre. |
10.00 | Scott Olsen | University of Texas | Developing Potency Measures of MSC and MSC-like Products. |
10.45 | COFFEE | ||
11.15 | Shirley O'Dea | Avectas | Solupore Non-viral Cell Engineering Platform. |
12.00 | Brian O’ Connor | Meira GTx | Challenges in Viral Vector Manufacture & Processes. |
12.45 | LUNCH | ||
14.00 | Qasim Rafiq | UCL | Automated Process Development and Manufacturing Strategies for ATMPs. |
14.45 | Mandana Haack-Sørensen | Rigshospitalet | Automation of cell therapy manufacturing: Lessons learned on compliance, product quality and production consistency. |
15.30 | COFFEE | ||
16.00 | Benjamin Gysi / Áine Adams | Takeda Pharmaceutical | Update on Takeda´s Cell Therapy Strategy Development. |
18.00 | Drinks Reception | ||
19.30 | Dinner @ Glenlo Sponsored by AccuScience | ||
DAY 02: 11TH NOVEMBER 2021 | |||
TIME | SPEAKER | COMPANY | TITLE OF TALK |
09.00 | Bruce Levine | UPenn | Development, Regulatory Approval, and Improvements in Engineered T Cell Therapies. |
09.45 | Massimo Dominici | University Hospital of Modena and Reggio Emilia Modena, Italy | Scaling up anti-cancer gene therapies: challenges and opportunities. |
10.30 | COFFEE | ||
11.00 | Prof. Garry Duffy | NUIG | Ambient Cell Transport and Implant Delivery Using Device and Biomaterial Approach. |
11.45 | Bernd Kullman | Sigilon Therapeutics | ATMP Manufacturing, Release, and Distribution: establishing a supply network and reducing risk for a time and temperature sensitive product. |
12.30 | LUNCH | ||
13.45 | Róisín O'Cearbhaill | Memorial Sloan Kettering | Overcoming challenges of cellular therapies in solid tumours. |
14.30 | Knut Niss | MustangBio | From MSCs to CARTs: How Manufacturing of ATMPs changed over the Last Decade. |
15.15 | COFFEE | ||
15.30 | Workshop | ||
18.30 | Dinner in The Galmont Sponsored by Meira GTx. | ||
DAY 03: 12TH NOVEMBER 2021 | |||
TIME | SPEAKER | COMPANY | TITLE OF TALK |
09.00 | Niamh Curran | HPRA | ATMPs- a regulatory update and lessons learned so far. |
09.45 | Nisha Durand | Mayo Clinic | Insights into the Operations of a small cGMP Cell Therapy Manufacturing Facility in an Academic Setting. |
10.30 | Patrick Hanley | Children’s National Hospital, The George | Overcoming Challenges in the Cellular Therapy Laboratory. |
11.15 | COFFEE | ||
11.45 | Michael O’Dwyer | ONK Therapeutics | Fundraising as a CGT start up: The agony and the ecstasy! |
12.30 | Jim Faulkner / Michael O’Dwyer | Venture Partner / ONK Therapeutics | Investing in Advanced Therapies. |
13.15 | LUNCH |
Fee & Cancellation Policy
Rate includes 2.5 days conference attendance with workshop on Day 2, coffees, lunches, a drinks reception and 2 dinners.
Early Bird Registration, before April 30th, 2021
[SALES ENDED]
€1,250 per attendee
2 or more from one company €1,000 per attendee
General Registration, after May 01st, 2021
[NOW AVAILABLE]
€1,500 per attendee
2 or more from one company €1,250 per attendee
Academic rate available upon request.
Cancellation possible until September 30th subject to a €100.00 cancellation fee.
Registration
Accommodation
Accommodation is available at the Glenlo Abbey Hotel, and can be booked directly via the hotel or via e-mail at reservation@glenloabbey.ie using promo-code ‘HiTechHealth’. Special rate of €160 B&B single or €170 for Twin or Double.
In addition, rooms are also available at the Harbour Hotel (www.harbour.ie) located in Galway City. Bookings can be made directly via the hotel or via e-mail at reservations@harbour.ie using promo-code ‘HiTechHealth’. Special rate of €129 B&B single or €139 for Twin or Double. Transfer will be organised for attendees staying in this hotel to the venue each morning of the meeting.
Contact
T: +353 1 963 1489
T: +353 1 960 2100
E: info@hitech-health.com
Five Key Considerations When Selecting a Cell and Gene Therapy CDMO
Many Cell and Gene Therapy (CGT) companies outsource product development and manufacturing activities to a Contract Development and Manufacturing Organisation (CDMO). It is critical to ensure that an informed decision is made when selecting a CDMO to prevent future...
HiTech Health Authorised by the MHRA to Perform Batch Importation and Certification of Investigational Medicinal Products (IMPs)
HiTech Health today announced that the company has been granted a Manufacturer’s/Importation Authorisation (MIA) for Investigational Medicinal Products (IMP) by the Medicines and Healthcare Products Regulatory Agency (MHRA). The company is now authorised to perform...
Cell Therapy: Points to Consider When Choosing a CDMO
At the Advanced Therapies Congress 2024 in London, Amina Al-Mossawi, a Qualified Person (QP) at Hitech Health, delivered vital insights on the crucial considerations for biotech firms when selecting a Contract Development and Manufacturing Organisation (CDMO). With...
Telephone
IE: +353-1-9631489
UK: +44-20-30267419
US: +1-857-3265835
Contact us
Get in touch anytime – we are always available to discuss your upcoming projects.